chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore arm for 2-3 days; This is a spontaneous report from a contactable consumer (Patient's mother). A 12-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 01Jul2021 (at the age of 12-years-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient did not report any medical history and concomitant medications were not reported. The patient had no prior vaccination within 4 weeks and no AE(s) following prior vaccination. The patient did not had relevant family medical history. On 01Jul2021, the reporter stated that with the first vaccine her daughter had a sore arm for 2-3 days. Patient did not have any AE(s) require a visit to emergency room and physician office. The outcome of sore arm was recovered on 03Jul2021.  Follow-up attempts are completed. No further information is expected. Batch/lot number not available for BNT162B2.
Patient reports tingling and numbness below left eye on cheekbone. Area was red, inflamed, and painful. Later the same day, blisters formed on right side of forehead at hairline. Patient states when she touched areas, her skin "fell off". Also, reported intermittent fever and headaches.  Patient was advised to take BENADRYL by mouth and use Cortizone-10 cream topically. Patient states some improvement the next day, but areas still remained for 5 to 6 day. There was no breathing issues or injection site reactions.
Information has been received from a medical technician referring to a patient of unknown age and gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On 31-MAY-2013, the patient received a dose of GARDASIL (lot#H021346 with expiration date 01-OCT-2015; dose and route were not reported). Then, on 03-OCT-2016 (also reported as "today"), the patient received a dose of GARDASIL 9 (lot # M024261 with expiration date 30-JUL-2018; dose and route were not reported). This was outside the recommendations per the prescribing information of the two vaccine. No adverse effects were reported. Additional information has been requested.
Pt described feeling nausea and chills - instructed to lie down and relax , (also to take a pain reliever if needed).
mild fever, sweats, light chills, a lot of muscle and body aches, mild shortness of breath, fatigue Time line: vax on Wed noon time, Thurs morning pains, Thurs evening much better after 2hr nap, Friday evening (now) 95% good.  This is just an fyi for your database
3 hours, post vax, pt turned red and jaundiced with chest tightness. Treated with Benadryl with resolution.
Night Sweats, Sweating with minor activity.  Shortness of breath.  Pressure in center of chest.  Fatigue.  Inability to exercise and continue normal activities since October 2021.Ca
I administered the PNEUMOVAX 23 at about 6:02 pm and asked him to sit down for 20 minutes and about 10 minutes later he stated that he was having tingling in his scalp and feet and was feeling very hot. He looked a little flush. Before the shot was given, he had stated that nystatin had caused his feet to get hot and he had to go to ER to get a shot of Benadryl. So, when he said he was having an allergic reaction, I asked him if he wanted an oral or IM dose of Benadryl and he wanted the shot. I gave him 50mg I.M. of diphenhydramine in left arm and sat with him on and off for about 10 minutes until he said he was feeling better. I asked it there was anything else I could do for him, and he said no, he was feeling fine. He left about 6:45 pm with his girlfriend.
2/23:  1st night:  Chills, slight fever, vomiting, diarrhea, headache.   2/24:  Next day:  nausea, chills, headache.  Did phone call visit with doctor.  Used Zofran and rested. 2/25 and 2/26:  Slight headache.  just rested
Narrative: COVID infection after completion of COVID vaccine series 12/23/20 pt with malaise, low grade fever, mild headache, mild cough 12/29/20 reported cough, body aches, sore throat x 1 week and loss of taste/smell, requested COVID test, COVID positive 12/30/20 reported mild cough 01/03/21 reported slight congestion 01/04/21 clinical resolution of COVID 03/11/21 COVID vaccine dose #1 04/09/21 COVID vaccine dose #2 06/15/21 reported myalgia, sore throat started 06/21/21 COVID test requested, COVID positive 06/22/21 reported cough and sore throat nearly resolved, new onset fatigue 06/23/21 no new symptoms 06/24/21 clinical resolution of COVID, no symptoms
Patient got the vaccine around 9:15am and around 1pm he was experiencing chills, sweats, fatigue and started vomiting and vomit was yellow in color. 911 was called and he was taken to the hospital. Nursing home staff notified us that patient did not eat anything that day and nothing 1am the day prior.
Awoke in morning with both hands (especially right) swollen. Was seen at local clinic, had x ray and blood work for rheumatoid arthritis. Hx of Hodgekins disease 1975, Breast Cancer 2001; hepatitis as child (probab. Hep A). Symptoms requ. MD and was observed for six weeks or more.
Patient received an influenza and pneumonia vaccine on 11/2/17 and called on 11/4/17 stating her arm was red, swollen, and felt like it had fever in it in the area where the shots were given (both given in same arm). Counseled her on using cold compress for 15 minutes and to take TYLENOL for pain and that symptoms should resolve within a couple of days, but if she felt like she needed to seek medical attention do so. Tried to call patient back several hours later and no answer.
Patient had a rash the circumference of a tennis ball that she noticed 4 days after the shot, patient said it was red and sore. Patient took Ibuprofen to help reduce the pain.
Had vaccine at MD office in am - returned to school. After school c/o dizziness and rash to mom. Patient was taken to hospital by mom. Was treated with oral BENADRYL and released. Provider was notified by hospital on 10/2/14.
Head ache,  heavy chest, winded easily unable to work out for 5 days-normally I run 7 days per week, High blood pressure for 6 days after, normal 90/60 blood pressure, resting heart beats per minute were  75, normal is 50. Dizzy and overall unable to walk and do normal activities.
PATIENT COMPLAINS OF SEVERE MEMORY LOSS MOST SPECIFICALLY SHORT TERM MEMORY.  WILL PUT A CALL IN TO HER PHYSICIAN
Information has been received from a health professional concerning a 20 year old female who on 02-FEB-2006 was vaccinated IM with a dose of Recombivax HB (lot # 648211/0864P). Subsequently the patient experienced "not feeling well" and fatigue. Unspecified medical attention was sought. At the time of the report, the patient had not recovered. There was no product quality complaint involved. Additional information has been requested.
Received the second dose of Pfizer COVID-19 vaccine on 1/9/2021 at 10:00. Woke up that night at 23:30 with chills and shaking. Stood up with extreme dizziness and lightheadedness. Temperature was 104F. Vomited approximately one hour later. Mild fever (101-102F), headache, nausea, chills, and weakness lasted for 30-36 hours. Acetaminophen taken every 6 hours and fluids maintained. Had a virtual e-visit and PA recommended visit to urgent care or ER. Went to urgent care 1/10/2021 at 16:00.
3/23/03 woke up with chest pains. Lasted about 8 hours. BP=130/110 3/24/03: BP 150/96; 130/94 no chest pain 3/26/03: BP 132/90 3/28/03: BP back to normal (110/80)
Hypotonic-hyporesponsive episodes x5 after immunizations.  9/15/08 Case closed w/medical records from PCP & hospital which accompanied report. FINAL DX: hypotonic-hyporesponsive episode s/p vaccination. Records reveal patient experienced good health on day of vaccination & became unconciousness, limp, pale within 5 min after received vaccinations.  Had additional 4 episodes of same in office prior to transfer to hospital then held overnight in ER for observation on monitor.  Had 1 episode of emesis after feeding & 1 episode of floppiness in ER.  Remained stable & d/c to home next AM.
diagnosed with Lichen Planus, given Clobetasol 0.05% cream, flare controlled but not gone
pt recv vax & 4hr later devel hives @ the inj site, & arm felt sore & hot;pt sx resolved w/in 24hr;
patient reported a great increase in fibromyalgia pain, fever, extreme body weakness, brain fog, pain from the middle of the ears to the top of the head and flu-like symptoms for 10 days.
I began with chills on the day after the vaccine,  Then about 6:00 pm I began to feel a little sick... I first had itching at the site of the injection, then about 8:00 PM I had an itchy arm in specific locations on that same arm... then it started itching on my right arm but not as much as the left arm,    Next, I had some itching on the back of my legs, upper thighs... About 11:00 pm is when I noticed the hives.  They were raised and about the size of a half a dollar.
Her arm felt a little sore after the 1st dose; This is a spontaneous report from a Pfizer Sponsored Program consumer (patient) reported for herself. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number and expiration date was not provided), via an unspecified route of administration on 31Mar2021 as a single dose for COVID-19 immunization. Medical history and concomitant medication were not reported. The patient mentioned that her arm felt a little sore after the 1st dose. It was reported that Patient had her 1st shot of the Pfizer Covid-19 Vaccine on the 31st together with her son. Together with her son have an appointment for the 2nd dose today (21Apr2021) as stated on the vaccination card. They went to the vaccination site today. And in the site, here's an army boy who checks people on the list before getting the shot, but their name was not on the list to take the 2nd dose today. They ended up missing the 2nd dose today. The outcome of the event was unknown.  No follow-up attempts are possible; Information related to batch/Lot number could not be requested
Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Vertigo. Concomitant products included LISINOPRIL and VERAPAMIL for an unknown indication.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced VERTIGO (Vertigo). At the time of the report, VERTIGO (Vertigo) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Client does have an allergy to antibiotics so she took some Benadryl prior to getting the flu shot and denied a reaction to it before. Post vax, she became flushed but had no signs of swelling or shortness of breath. I called the pt back at 12:00 on this date and she stated her tongue swelled and that she took some more Benadryl after I left. At 13:45 on 10/31/01, telephone call to MD's office made aware of above. On 11/6/01, the pt had chills and was thought she might have URI, so a sterile catheter was done for UA.
This patient was scheduled to have Pediarix (DTap/Hep B/ IPV) but received Kinrix (DTap/ IPV) and Engerix (Hep B). All vaccine doses and scheduled vaccines are the same.  The patient did not receive the suggested combined vaccination.
dizziness; fever; chills; nausea; vomiting; headache; body ache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), PYREXIA (fever), CHILLS (chills), NAUSEA (nausea) and VOMITING (vomiting) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced DIZZINESS (dizziness), PYREXIA (fever), CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting), HEADACHE (headache) and MYALGIA (body ache). At the time of the report, DIZZINESS (dizziness), PYREXIA (fever), CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting), HEADACHE (headache) and MYALGIA (body ache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Patient committed suicide the morning of March 2, 2021. He stepped in front of a truck on a highway.  I consulted with pharmacy and they said that I should report even if the 2 most likely have nothing to do with each other.
Pt was vaccinated on 1/14/2021 and presented with diabetic ketoacidosis on 1/16/2021. In addition to DKA she developed bilateral pleural effusions. She had previously well-controlled DM with no prior history of DKA. She has no cardiac issues to explain her pleural effusions.
Drop in hemoglobin level; Idiopathic thrombocytopenic purpura; This is a spontaneous report from a contactable consumer. An 88-year-old female patient received the 2nd dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on 04Feb2021, at single dose, for COVID-19 immunisation. Medical history included diabetes mellitus, hypertension and other unspecified conditions. Patient did not have known allergies and did not have COVID-19 prior to vaccination. Concomitant included unspecified multiple medications. Previously the patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech) for COVID-19 immunisation. The patient did not receive other vaccine in four weeks. The patient experienced drop in hemoglobin level resulting in idiopathic thrombocytopenic purpura (ITP) on 04Feb2021 with outcome of not recovered. The event resulted in physician office visit and emergency room visit. Patient had no history of ITP prior to vaccination. The event was considered serious as caused patient's hospitalization and as life threatening. The patient underwent lab tests and procedures which included hemoglobin: drop on 04Feb2021. Therapeutic measures were taken as a result of the event and included treatment with multiple unspecified drugs. It was unknown if she was tested for COVID-19 after vaccination.  The information on the lot/batch number has been requested.
Staff member reports not feeling herself, dizziness, fatigue, cough, forgetfulness, congestion
sore arm; This is a spontaneous report received from a contactable consumer (Pfizer employee). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received her first dose of the vaccine, and that the next day she had a sore arm. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
She said the shot hurt and it felt like a cramp in her left arm where shot given.  she got chills and a headache later that night. she also got soreness at the back of her neck. her arm is still bruised at the site.
This spontaneous report was received from a medical assistant regarding a patient of unknown demographics. There was no information regarding pertinent medical history and drug allergies or reactions. On 17-JAN-2019 the patient was vaccinated with improperly stored VARIVAX, lot # N023963, expiration date- 01-SEP-2019, for prophylaxis (product storage error). Concomitant therapies included sterile diluent. Temperature excursion was for the time frame of 50 minutes for 15F to 46F. Vaccine had previous temperature excursion of 6F to 14 F for 30 minutes and 15 F to 46F for 30 minutes. The call was because of a data logger. Patient experienced no adverse event.
This spontaneous reports as received from a patient's mother refers to a 12 months old female patient. She reported that her daughter had the "first doses" of M-M-R II (route and lot# unspecified), VARIVAX (Merck) (route and lot# unspecified) and a dose of influenza virus vaccine (manufacturer unspecified) (route, dose and lot# unspecified) on 15-OCT-2012. Concomitant medications included ranitidine and vitamins (unspecified). The patient's mother reported that the last night (23-OCT-2012) the patient had a fever of 101.6 degrees Fahrenheit and no other adverse reactions. The patient was treated with TYLENOL. The patient the next morning (on 24-OCT-2012) had a normal temperature of 98 degrees Fahrenheit. The patient's mother feared that the temperature might "spike back up" later on that day. At the time of the report, the patient was recovering of fever. Additional information is not expected.
Transverse myelitis with lower limb weakness and numbness.  Treated with steroids and IVIG.
3 days post vaccination sore throat, fevers to 103.0 F, general fatigue and malaise. 7 cm x 7 cm erythematous site of injection and tender. CBC normal, negative Monospot.
Area of vaccine administration was reddened, swollen, warm to touch.  ER diagnosed it on 9/10/2013 as cellulitis where skin was punctured from syringe.
19Mar98 pt exp rash on chest,shoulders & swollen glands right neck. Pt to see ER.
pregnant woman was given the vaccine; This spontaneous pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnant woman was given the vaccine) in a 30-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included Miscarriage in 2020 and Alcohol use (social drinking). Concomitant products included DOCUSATE SODIUM (COLACE) for Constipation, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 09-Jan-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 05-Jul-2021. On 09-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant woman was given the vaccine). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 09-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnant woman was given the vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided.; Sender's Comments: Based on the current available information and the temporal association between the use of the product and the start date of the event a causal relationship cannot be excluded.
1/13 vaccination I started having HA about 7pm that night. BP was elevated; 170/110. Kept monitoring. Would come down every day. Valcartin increase per PCM and it took care of the BP increase after 3 days.
she got pretty sick; This is a spontaneous report from a Pfizer sponsored program received from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 25Mar2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient got the first dose last 25Mar2021, and the second would be on 15Apr2021. She was asking if it was okay for her to take the second dose on an earlier date because she was having vacation. She said as well that she got pretty sick after the first dose, in Mar2021. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient in 10/25/12 to get flu vaccine. At some point through the night woke up with hives and chills. Hives started on trunk, but then redness all over. Also experienced nausea, shakes and chills, dizziness and lightheaded. Came into office and received 0.3mg of epinephrine.
Information has been received from a physician concerning a new female employee in her late 20's early 30's, who in approximately October 2002, was vaccinated with her second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  In September 2002, on an employment physical a titer was drawn which was negative for rubella.  Unspecified medical attention was sought.  The physician also reported that another new female employee who was vaccinated with the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) had a titer which was negative for measles (WAES # 02100USA00839).  Additional information has been requested.
as soon as injection was made, it felt like liquid shooting up my neck.  I had the usual arm pain, fatigue, fever, lasting about 24 hours. For next 11 days I was sick to stomach with very mild fever that would come and go, but nothing unbearable. On about day 13 after vaccination, I had a sharp, pulsating pain in the injection site. pulsated for about 5 min, then stopped.  Over the next week, at random times, I feel pain in the injection site, not my whole arm, and feverish off and on. I have the stomach discomfort off and on as well.  I have had many injections in my life and have never felt liquid run up my neck.  Did it go into a vein?  Is the vaccination as effective?  Why am I continuing to have pain?
Rash all over; Itching; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date not reported), via an unspecified route of administration, on an unspecified date (reported as last week), as dose 1, single, for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that, the patient got her first Pfizer vaccine for COVID last week, 24 hours later she had rashes all over, much of her body and itching. The patient took Benadryl and Prednisone as treatment of the event, and it was keeping it under control. The reporter questioned if patient could go ahead with second vaccine which was scheduled for a couple of weeks from the time of report or was it possible that she had a bad allergic reaction and she should not get the second dose. The outcome for the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
2 hours after flu shot, complained of feeling weak, flushed, thick tongue.  Blood pressure: 112/80; Pulse: 60; diffuse erythematous maculopapular rash arms, chest, back.  Non pruritic.
Pain at injection site immediately following vaccination and continued through today 8/18/18. Pain with ADL's, sleeping on left side and all the time to some degree. Physical therapy has reduced pain level.
Noticed itching at 11:55AM on 10/5/2018, saw redness of circle about one & a half inches in diameter at the site of injection. Slight discoloration only where needle entered. Some swelling.
pt requested a pf vaccine and was given a vaccine with preservative from a multi-dose vial